To investigate the effect of alterations to NHE1 regulation in triple-negative breast cancer cells, we replaced endogenous NHE1 with NHE1 protein containing mutations to various regulatory regions. This evidence concerns the gene SLC9A1 and triple-negative breast carcinoma.